04:22 PM EST, 11/03/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) reported Q3 earnings late Monday of $0.06 per diluted share, down from $0.32 a year earlier.

Analysts polled by FactSet expected $0.09.

Revenue in the three months ended Sept. 30 rose to $599 million from $401.6 million a year earlier.

Analysts surveyed by FactSet expected $580.2 million.

The company expects Q4 revenue of $605 million to $625 million. Analysts surveyed by FactSet expect $631.7 million.

The company projects 2025 revenue of $2.335 billion to $2.355 billion, compared with the previous forecast of $2.3 billion to $2.4 billion. Analysts polled by FactSet expect $2.344 billion.

Shares of the company rose 3.1% in after-hours trading.